Search Results - "Lampe, Christina"

The Xanthomonas effector XopL uncovers the role of microtubules in stromule extension and dynamics in Nicotiana benthamiana by Erickson, Jessica L., Adlung, Norman, Lampe, Christina, Bonas, Ulla, Schattat, Martin H.

“…Summary Xanthomonas campestris pv. vesicatoria type III‐secreted effectors were screened for candidates influencing plant cell processes relevant to the…”
Get full text

Social and medical needs of rare metabolic patients: results from a MetabERN survey by Sestini, Sylvia, Paneghetti, Laura, Lampe, Christina, Betti, Gianni, Bond, Simon, Bellettato, Cinzia Maria, Maurizio, Scarpa

“…Many surveys have been performed over the years to assess the medical and social requirements of patients with a rare disease, but no studies have focused…”
Get full text

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease by Scarpa, Maurizio, Almássy, Zsuzsanna, Beck, Michael, Bodamer, Olaf, Bruce, Iain A, De Meirleir, Linda, Guffon, Nathalie, Guillén-Navarro, Encarna, Hensman, Pauline, Jones, Simon, Kamin, Wolfgang, Kampmann, Christoph, Lampe, Christina, Lavery, Christine A, Teles, Elisa Leão, Link, Bianca, Lund, Allan M, Malm, Gunilla, Pitz, Susanne, Rothera, Michael, Stewart, Catherine, Tylki-Szymańska, Anna, van der Ploeg, Ans, Walker, Robert, Zeman, Jiri, Wraith, James E

“…Mucopolysaccharidosis type II (MPS II) is a rare, life-limiting, X-linked recessive disease characterised by deficiency of the lysosomal enzyme…”
Get full text

A conserved microtubule-binding region in Xanthomonas XopL is indispensable for induced plant cell death reactions by Ortmann, Simon, Marx, Jolina, Lampe, Christina, Handrick, Vinzenz, Ehnert, Tim-Martin, Zinecker, Sarah, Reimers, Matthias, Bonas, Ulla, Erickson, Jessica Lee

“…Pathogenic Xanthomonas bacteria cause disease on more than 400 plant species. These Gram-negative bacteria utilize the type III secretion system to inject type…”
Get full text

Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome) by Kampmann, Christoph, Abu-Tair, Tariq, Gökce, Seyfullah, Lampe, Christina, Reinke, Jörg, Mengel, Eugen, Hennermann, Julia B, Wiethoff, Christiane M

“…Mucopolysaccharidosis (MPS) IVA is a rare lysosomal storage disorder with multiple skeletal and non-skeletal abnormalities requiring multiple surgical…”
Get full text

Surgical management of neurological manifestations of mucopolysaccharidosis disorders by Alden, Tord D., Amartino, Hernán, Dalla Corte, Amauri, Lampe, Christina, Harmatz, Paul R., Vedolin, Leonardo

“…The mucopolysaccharidosis (MPS) disorders are ultra-rare lysosomal storage disorders associated with progressive accumulation of glycosaminoglycans (GAGs) in…”
Get full text

Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries by Magner, Martin, Almássy, Zsuzsanna, Gucev, Zoran, Kieć-Wilk, Beata, Plaiasu, Vasilica, Tylki-Szymańska, Anna, Zafeiriou, Dimitrios, Zaganas, Ioannis, Lampe, Christina

“…Mucopolysaccharidosis IVA (MPS IVA), or Morquio A syndrome, is a rare inherited metabolic disorder caused by deficiency of the lysosomal enzyme…”
Get full text

The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy by Wiesinger, Anna-Maria, Bigger, Brian, Giugliani, Roberto, Scarpa, Maurizio, Moser, Tobias, Lampe, Christina, Kampmann, Christoph, Lagler, Florian B

“…Mucopolysaccharidoses (MPS) are a group of lysosomal storage diseases (LSDs), characterized by the accumulation of glycosaminoglycans (GAGs). GAG…”
Get full text

Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)-10-year follow-up of patients who previously participated in an MPS VI survey study by Giugliani, Roberto, Lampe, Christina, Guffon, Nathalie, Ketteridge, David, Leão-Teles, Elisa, Wraith, James E., Jones, Simon A., Piscia-Nichols, Cheri, Lin, Ping, Quartel, Adrian, Harmatz, Paul

“…Mucopolysaccharidosis VI (MPS VI) is a clinically heterogeneous and progressive disorder with multiorgan manifestations caused by deficient…”
Get full text

Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management by Solanki, Guirish A., Martin, Kenneth W., Theroux, Mary C., Lampe, Christina, White, Klane K., Shediac, Renée, Lampe, Christian G., Beck, Michael, Mackenzie, William G., Hendriksz, Christian J., Harmatz, Paul R.

“…Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio-Brailsford or Morquio A syndrome, is a lysosomal storage disorder caused by a deficiency of the…”
Get full text

Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system by Scarpa, Maurizio, PhD MD, Bellettato, Cinzia Maria, PhD, Lampe, Christina, Dr med, Begley, David J., BSc PhD

“…Pharmacological research has always focused on developing new therapeutic strategies capable of modifying a disease's natural history and improving patients'…”
Get full text

The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers by Tylki-Szymańska, Anna, Almássy, Zsuzsanna, Christophidou-Anastasiadou, Violetta, Avdjieva-Tzavella, Daniela, Barisic, Ingeborg, Cerkauskiene, Rimante, Cuturilo, Goran, Djiordjevic, Maja, Gucev, Zoran, Hlavata, Anna, Kieć-Wilk, Beata, Magner, Martin, Pecin, Ivan, Plaiasu, Vasilica, Samardzic, Mira, Zafeiriou, Dimitrios, Zaganas, Ioannis, Lampe, Christina

“…Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by defects in genes coding for different lysosomal enzymes which degrade…”
Get full text

Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS) by Stepien, Karolina M, Gevorkyan, Anait K, Hendriksz, Christian J, Lobzhanidze, Tinatin V, Pérez-López, Jordi, Tol, Govind, Del Toro Riera, Mireia, Vashakmadze, Nato D, Lampe, Christina

“…Mucopolysaccharidoses (MPS) are rare, inherited disorders associated with enzyme deficiencies that result in glycosaminoglycan (GAG) accumulation in multiple…”
Get full text

Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey by Stepien, Karolina M, Kieć-Wilk, Beata, Lampe, Christina, Tangeraas, Trine, Cefalo, Graziella, Belmatoug, Nadia, Francisco, Rita, Del Toro, Mireia, Wagner, Leona, Lauridsen, Anne-Grethe, Sestini, Sylvia, Weinhold, Nathalie, Hahn, Andreas, Montanari, Chiara, Rovelli, Valentina, Bellettato, Cinzia M, Paneghetti, Laura, van Lingen, Corine, Scarpa, Maurizio

“…Inherited Metabolic Diseases (IMDs) are rare diseases caused by genetic defects in biochemical pathways. Earlier diagnosis and advances in treatment have…”
Get full text

RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15, 1565 by Wiesinger, Anna-Maria, Bigger, Brian, Giugliani, Roberto, Lampe, Christina, Scarpa, Maurizio, Moser, Tobias, Kampmann, Christoph, Zimmermann, Georg, Lagler, Florian B.

“…The journal retracts the article, An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis [...]…”
Get full text

A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations by Herzog, Andreas, Hartung, Ralf, Reuser, Arnold J J, Hermanns, Pia, Runz, Heiko, Karabul, Nesrin, Gökce, Seyfullah, Pohlenz, Joachim, Kampmann, Christoph, Lampe, Christina, Beck, Michael, Mengel, Eugen

“…Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficiency, acid maltase deficiency, OMIM # 232300) is an autosomal-recessive…”
Get full text

RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis by Wiesinger, Anna-Maria, Bigger, Brian, Giugliani, Roberto, Lampe, Christina, Scarpa, Maurizio, Moser, Tobias, Kampmann, Christoph, Zimmermann, Georg, Lagler, Florian

“…Mucopolysaccharidosis (MPS) is a group of rare metabolic diseases associated with reduced life expectancy and a substantial unmet medical need…”
Get full text

Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP) by Hendriksz, Christian J., Giugliani, Roberto, Harmatz, Paul, Lampe, Christina, Martins, Ana Maria, Pastores, Gregory M., Steiner, Robert D., Leão Teles, Elisa, Valayannopoulos, Vassili

“…Objective To outline the design, baseline data, and 5-year follow-up data of patients with mucopolysaccharidosis (MPS) VI enrolled in the Clinical Surveillance…”
Get full text

Comparison of Rebound Tonometry, Perkins Applanation Tonometry and Ocular Response Analyser in Mucopolysaccharidosis Patients by Wasielica-Poslednik, Joanna, Butsch, Christina, Lampe, Christina, Elflein, Heike, Lamparter, Julia, Weyer, Veronika, Pitz, Susanne

“…To investigate the feasibility and to compare three devices measuring intraocular pressure (IOP) in mucopolysaccharidosis patients (MPS): iCare rebound…”
Get full text

Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany by Dilger, Hansjörg, Leissner, Linn, Bosanska, Lenka, Lampe, Christina, Plöckinger, Ursula

“…Mucopolysaccharidosis VI (MPS VI) is an inherited lysosomal storage disease caused by a mutation of the gene for arylsulfatase B (ASB). Of the thirty-one…”
Get full text